Skip to main content

Advertisement

Table 2 Characteristics of the included patients in this meta-analysis

From: Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis

Author Year Age Sex(male%) HBV DNA(log10) HBeAg(+), % ALT, U/L CD4+T Cell/μl
Chen [15] 2017 42 55 5.02 NR NR NR
Chen [16] 2013 38 82 5.6 58.3 246 100
Gao [17] 2016 37 58.6 5.03 NR NR NR
He [18] 2015 39 64 5.02 NR NR NR
Jain [12] 2006 39 84.2 7.8 76 60 180
Li [13] 2016 36 82.8 3.59 25.8 29 200
Liu [19] 2017 31 59 NR 34.1 NR NR
Luo [20] 2016 54 65 NR 15 NR 41
Min Zhou [21] 2016 36 51 NR NR NR NR
Wang [14] 2016 29 0 3.83 29 NR 322
Yan Zhou [22] 2016 38 57.2 5.04 NR NR NR
  1. HBV DNA, HBeAg, ALT, and CD4+T cell were all expressed in mean. NR: not report